Complications of Living Donor Liver Transplantation
Living donor liver transplantation carries significant complications for both donors and recipients, with donors experiencing an overall complication rate of approximately 24.7%, donor mortality of 0.18%, and recipients facing technical complications in 26% of cases, with biliary complications being the most frequent serious morbidity affecting 19-43% of recipients.
Donor Complications
Overall Risk Profile
The most comprehensive recent meta-analysis demonstrates that approximately one-quarter of living liver donors experience complications 1. The breakdown is critical:
- Minor complications: 17.3% (Clavien-Dindo grade I-II)
- Major complications: 5.5% (Clavien-Dindo grade III or higher)
- Donor mortality: 0.18% 2
Specific Donor Complications by System
Biliary complications are the most common serious donor complication, occurring in approximately one-third of donors and typically managed conservatively 2. Biliary fistulas represent the predominant biliary issue and usually resolve without surgical intervention.
Psychological complications affect 7.6% of donors and represent the most frequent complication category overall 1. This includes depression and anxiety affecting approximately 8% of donors long-term 3.
Wound-related complications occur in 5.2% of donors 1, with incisional hernias developing in up to 20% of donors over time 3. Diaphragmatic hernias are uncommon but potentially life-threatening.
Respiratory complications affect 4.9% of donors 1.
Cardiovascular complications have the lowest incidence at 0.8% 1.
Right vs. Left Lobe Donation
Right lobe donors face significantly higher complication rates compared to left lobe donors, including higher overall complication rates and more Clavien II and IIIa complications 2. Right hepatectomy requires meticulous dissection of the right hepatic artery, portal vein, bile duct, and suprahepatic vein, increasing technical complexity.
Long-Term Donor Outcomes
Physical recovery: Approximately 80% of donors return to work within 3 months, though 27% report chronic pain and one-quarter experience ongoing activity limitations 3. Nearly all donors report persistent incisional numbness after the first postoperative year.
Financial burden: Persists for 22-40% of donors even two years post-donation 3.
Mortality: Long-term survival parallels matched controls, though donors have higher risk of suicide and certain cancers 3.
Quality of life: Physical quality of life typically returns to baseline within 6-12 months, though cosmetic concerns affect body image and mental health 3.
Recipient Complications
Overall Complication Rates
Recipients face substantial morbidity, with 38-47% experiencing complications within 90 days 4. The 5-year graft survival is 69% overall (78% in children, 63% in adults) 2.
Technical Complications (26% of graft losses) 2
Biliary complications are the most frequent, occurring in:
Management approaches include:
- ERCP and sphincterotomy: 35.3%
- Percutaneous drainage: 38.0%
- Reoperation: 26.3% 4
Anastomotic stenosis occurs in 4-9% of cases, typically presenting within the first year 2.
Vascular complications:
- Hepatic artery thrombosis: 1-7% incidence, with devastating consequences including 5-year graft survival of only 27.4% 2. Approximately 50% require revascularization, while the remainder need retransplantation.
- Portal vein thrombosis: 2.1-26% incidence 2
- Outflow obstruction: 1-6% incidence 2
- Overall vascular complications: 6-9% in recipients 4, 5
Hemorrhage requiring reoperation: 9-14% of recipients 4
Other Major Complications
Infection: Accounts for 18% of graft losses 2
Rejection:
- Acute rejection: 8% of graft losses, affecting 15-30% of recipients but successfully treated in almost all cases 2
- Chronic rejection: Less than 2% of graft losses 2
Small-for-size syndrome: 12.6% of recipients 5
Gastrointestinal complications: 19.8% 5
Neurological complications: 26.3% 5
Renal complications: 21% 5
Mortality
Overall recipient mortality: 44.9% in one large series, with in-hospital mortality of 28.7% and late mortality of 16.2% 5. Vascular complications and small-for-size syndrome have significant effects on mortality.
Critical Practice Points
The 2024 EASL guidelines mandate that LDLT experience should be concentrated in high-volume centers with sufficient training and experience to minimize risks 6. The donor liver remnant must be at least 30% of pre-donation volume or mass 6.
Systematic screening for hemostatic and prothrombotic disorders in potential donors is recommended to prevent increased morbidity, as prothrombotic abnormalities can be transmitted to recipients 7.
Common pitfall: Biliary, hemorrhagic, and vascular complications at 30 days post-transplant are associated with significantly lower 1-year patient survival (biliary: aHR 5.14; hemorrhage: aHR 2.54; vascular: aHR 2.88) 4, requiring aggressive early management.
Donor follow-up: Current evidence supports extending donor monitoring beyond one year, with particular emphasis on psychiatric screening and targeted health surveillance 3.